This item is part of Stockwatch's value added news feed and is only available to Stockwatch subscribers.

Here is a sample of this item:

by Mike Caswell

Bristol-Myers Squibb Company has asked that a judge summarily dismiss a lawsuit the company faces from the estate of former Vancouver promoter Sameh Magid over an $8.83-million (U.S.) gambling debt. The company says that the lawsuit has absolutely no prospect of success. The case, which stems from a prescription drug treatment gone awry, comes far too late, beyond the provisions of the Limitation Act, Bristol-Myers says.

The request from Bristol-Myers comes just over one year after Mr. Magid's estate filed a lawsuit against the company in the Supreme Court of British Columbia. The suit, dated Feb. 7, 2019, claimed that Mr. Magid developed a gambling problem after he started taking a drug called Abilify. The drug was supposed to treat depression, bipolar disorder and schizophrenia, but according to the lawsuit, it led to Mr. Magid developing compulsive behaviour. In September, 2014, Mr. Magid took out large lines of credit at the Mandalay Bay casino in Las Vegas and incurred a substantial debt, the suit states.

The remainder is available to Stockwatch subscribers.
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS